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Summary: Twenty eight clinical chemical blood parameters were studied with respect to intra-individual
variations. Both short tenn variations, within one day and during one week, and long term variations, during a
six months period, were investigated in groups of 62, 16 and 274 individuals. Moreover, critical differences
were calculated from the total variations, i.e. physiological (personal) and analytical variations. The influen-
ces of external factors (sex, smoking, and oral contraceptives) were been studied.
It was concluded that the use of laboratory data in clinical diagnosis is considerably improved when intra-indi-
vidual variations and critical differences are used.
Kurz· und langzeitige intraindividuelle Änderungen sowie kritische Differenzen klinisch-chemischer Kenn-
größen
Zusammenfassung: Die intraindividuellen Änderungen von 28 klinisch-chemisch bestimmten Blutbestand-
teilen wurden untersucht. In Gruppen von 62,16 und 274 Probanden wurden sowohl kurzzeitige Änderungen
innerhalb eines Tages und während einer Woche als auch langzeitige Änderungen während eines halben
Jahres verfolgt. Zusätzlich.wurden aus den Gesamt-Änderungen, d.h. physiologischen (individuellen) und
analytischen Variationen, kritische Differenzen berechnet. Weiterhin wurden äußere Einflüsse wie Ge-
schlecht, Rauchen und Einnahme oraler Kontraceptiva untersucht.
Aus den Ergebnissen wird geschlossen, daß die Verwendung von Labordaten in der klinischen Diagnostik
wesentlich verbessert wird, wenn intraindividuelle Variationen und kritische Differenzen benutzt werden.
Lntroduction
In medical practice physicians request clinical labor-
atory tests to assist in diagnosis, to suggest a type of
treatment and to monitor the patient.
In general, support is sought for the confirmation of
a preliminary diagnosis based on the patient's history
and physical examination. The latter is often re-
garded äs subject to personal Interpretation whilst
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laboratory tests are considered to provide more ob-
jectiVe Information. As far äs clinical chemistry is
concerned, the Information is obtained by chemical
and physical procedures, estimating characteristic
values.
Data obtained by laboratory investigation are des-
tined for use in clinical decision making. As a matter
of fact, for the diagnosis of a certain disease the data
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obtained from the diseased population are compared
with those obtained from other comparable popula-
tions. The latter may preferably consist of healthy
individuals although it is not always obvious how to
define "healthy" in this context. Comparison with
data from non-healthy individuals, but not having
the investigated disease, also make sense.
The commonly used "reference ränge" is generally
determined by analysis of a large number of blood
samples taken from an apparently healthy group of
individuals at a certain time (transverse reference
values). Data obtained from blood samples of pa-
tients deviating from this ränge of "reference
values" obtained from the healthy population, may
indicate an unusual or even a pathological Situation.
The investigated healthy reference population fre-
quently consists of selected groups such äs blood do-
nors from the blood transfusion Service, laboratory
personal or rriedicine students. Evidently, this is not
an ideal Situation; several selection mechanisms may
be present.
Comparison of patients' values with transverse refer-
ence values is only valid when the biological variabil-
ities of reference population and target population
are comparable to a large extent, e. g. the sex compo-
sition of the groups, the age of the persons in the
groups, etc.
An usual finding is that the ranges of values for the
laboratory determinations from healthy and non-
healthy populations and the population of patients
with the disease to be studied, overlap to a greater or
lesser extent. Decision limits must then be deter-
mined.
The Information obtained by so-called longitudinal
investigation is completely different (1-4). In this
type of study the parameters studied are determined
in consecutive blood samples of a single individual
during a longer period. Longitudinal appreciation
has an advantage in comparison to the transverse ap-
proach. The patient is his own reference, so changes
in parameter values, within the transverse reference
ränge, or developing trends in consecutive values
may be very indicative for underlying pathology.
E. g. thyroxine serum levels in one patient changing
within a certain period from 60 nmol/1 to 128 nmol/1
may indicate progressive hyperthyroidism, although
both values are within the transverse reference ränge
(55-145 nmol/1). However, the change from 60
nmol/1 to 128 nmol/1 is not ükely to be a physiologi-
cal one and may confirm the diagnosis of hyperthy-
roidism.
Assessment of the meaning of longitudinal data re-
quires a knowledge of intra-individual variability. A
real problem is that sufficient data about intra-indi-
vidual Variation over a period of time are not availa-
ble for most clinical chemical parameters. A reliable
longitudinal appreciation of data is thereföre not
generally possible. The purpose of the present inves-
tigation is to assess the intra-individual Variation of
28 clinical chemical parameters in a large population
of healthy vohmteers. Moreover, the so called criti-
cal differences will be calculated and considered.
Often* the latter coiicern only the analytical bias. In
the present study the intra-individual biological vari-
ability is also taken into account for the calculation
of critical differences. Oür study concerns the deter-
mination of the intra-individual variance in three dif-
ferent time spans:
— within^one-day
— within^one-week (day-to^day)
— within-six-months (month-to-month)
Extra attention has been paid to the constancy of
analytical procedures and the pre-analytical treat-
ment of the blood samples.
Probarods, Materials and Methods
Individuals
The investigation of the within-one-day intra-individual Variation
has been started with a group of 62 apparently healthy volunteers
ages 18—53 years. The group contained 23 males and 39 females
from hospital laboratory personal (20 persons), medical staff (16)
and students (26 persons).
Using a smallgroup (n = 16) an intermediate time span was inves··
tigated studying longitudinal intra-individual variations during a
one week period.
Investigation of six months intra-individual Variation was started
with a grpup of 300 völunteers.
In the first two months 21 persons withdrew for various reasons
(inconvenience, departure from the area, etc.). During the six
month period another five persons were removed from the study
on account of apparent disease. As a result the group of individu-
als participäting in the study consisted of 274 volunteers ages 18
to 63 years old. Some were workers in various branches of chemi^
cal industry (84 persons), pthers were hospital laboratory person-
al (82 persons) and clerical personal (28 persons), male and fe-
male nurses (63 persons) and volunteers from a variety of other
groups (17 persons). The group was subdivided in 148 males and
126 females including 72 male smokers, 54 female smokers and
61 females taking oral contraceptives.
Body weight, height and age of all individuals were tegistered. No
gross restrictions were imposed on diet or activity during the
study. The nature and purpose of the study were explained be-
fore-hand to all individuals, arid its design was approved by the
Ethical Committee.
All individuals were judged to be healthy at the beginning of the
study by medical interview; no person suffering from chronic or
reeürrent illness was admitted.
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During the studies no serious illness or injury was observed apart
from haematoma after venipuncture. No drugs, apart from oral
contraceptives, were involved.
Scheme of venipuncture
For the within-one-day period, all blood specimens from one indi-
vidual were taken at fixed times i. e. 8.30 and 11.00 a. m. and 2.00
and 4,30 p.m. in the course of one day. These times were chosen
because in normal practice about 95% of blood samples for analy-
sis are drawn within these hours.
For the day-to-day Variation during six days 16 volunteers were
daily subjected to venipuncture. For the month-to-month period
274 volunteers were subjected to venipuncture monthly over a
period of six months. For each volunteer the venipuncture was
carried out at the same time of the day.
Specimens
The individuals had a 10 to 15 minutes rest in a sitting position
before venipuncture. While the subject was in a comfortable sit-
ting poscure blood was collected in vacuum blood collection tubes
(Terumo®). Brief tourniquet pressure was released immediately
before venipuncture. The serum samples of all individuals were
frozen at -78 °C until the day of analysis, when all specimens of
one individual were thawed at room temperature, mixed tho-
roughly and analysed in the same run.
Tab. 1. Symbols for the variance components used in this study.
sj = total variance of one individual from a reference population.
»A T aO
s| = biological variance
+ s* Sp = intra-individual variance
s? = inter-individual variance
sf = absent in this study
^ = analytical variance
SA " ss + SL ss = variance within the run
s? = variance between runs
SL = absent in this study
so = "other" variance, e.g. specimen collection
Corresponding coefficient of Variation (percentages) are denoted
by CVr, CVB and CVA.
Analyt ical procedures
The automated analyses used were the same äs used in daily rou-
tine for analysis for patient specimens.
Variance components
In general three variance components can be distinguished, a bio-
logical, an analytical and an "other one" (tab. 1) (5). For the pres-
ent investigation the "other" cornponent can be neglected: The
main part of the "other" cornponent is usually specimen collec-
tion; in the present study this was minimized by standardization of
coilection by using a vacuum collecting System. For each individu-
al total individual variances (s£) can be calculated from the obser-
vations. Assuming the analytical cornponent to be known, the bio-
logical one can be computed from:
critical difference
4 - st
In this study we only consider the intra-individual Variation (no
inter-individual variance). Moreover all samples from one indi-
vidual were analysed in the same run (no inter-run variance). Ac-
cording to the terrninology of table l, SB = SP and SA = ss, the
reported results are mainly given in coefficients of Variation (per
centages). Forinstaiice CVß = SB/X · 100% whereas the mean is
based on the observations of one individual.
To characterize the variability of CVP for each parameter, three
characteristics of the histogram of 62, 16, 274 CVP values will be
reported in the tables:
— the percentage of individuals with CVr > CV$ (denoted by
nvar.)
— the median value, denoted by CVpso
— the ninety percentile value, denoted by CVP90
Critical differences
The critical difference die has been developed äs a tool to follow
the course of one laboratory parameter in one individual in con-
secutive measurements. The critical difference is dependent on
the total variance s| for the one individual concerned. Because in
dK =
or
dK = 2V2CV* = 2\/2(CVprT~CV|)
our study the critical difference is predominantly dependent on
the intra-individual variance Sp and the within-run variance s|, it
can be written äs:
dK
or
£ + *l) (in units)
die = 2V2(CV* + CVQ (in percentages)
When longitudinal investigations are performed in clinical labora-
tory practice, the analytical variance s^ is composed of the intra-
run variance s| and the inter-run variance SL; the critical differ-
ence is then calculated äs:
J + SA) (in units)
or
dK =
Statistical methods
(in percentages)
Each parameter in this study was investigated with the Friedman
rank test (6) to determine whether a systematic pattern could be
found. Such a pattern could be either an upward or a downward
trend or a systematic low or high value at one particular point.
Several two group comparisons (like male versus female, smok-
ers/non smokers) were performed using the Mann- Whitney test
(7). Correlations were studied using the Spearman rank correla-
tion test (7).
J. Clin. Chem. Cün. Biochem. / Vol. 23,1985 / No. l
10 Costongs et al.: Intra-individual variations and critical differences of laboratory parameters
Results
Evaluation of serial changes in a patient laboratory
results requires an appreciation of the changes oc-
curring in the healthy individual s a result of analyt-
ical Variation and normal physiological fluctuations.
More than 28 years ago R. J. Williams (8) introduced
the concept of biochemical individuality and demon-
strated the uniqueness of each individual in many
physiological and biological respects.
Analytical Variat ion
The analytical within-run variations (CVS) are pres-
ented in terms of coefficients of Variation (%) in ta-
ble 2. With the exception of the creatine kinase MB
(4.3%), iron (3.8%), ferritin (10.0%), thyroxine
(6.0%) and triiodothyronine (5.7%), the CV was al-
ways less than 2.9%. Effects of long term storage of
frozen specimens during 6 months at -78 °C were
investigated by analysing a number of samples di-
rectly after the blood was taken and freezing parts of
these specimens. The frozen samples were analysed
after consecutive periods of storage at -78 °C (from
one month up to six months). The total coefficient of
Variation calculated from the results of seven sam-
ples from the same specimens with increasing stor-
age time, never exceeded the analytical coefficient of
Variation. Consequently, no significant influence of
storage at -78 °C was found.
Within-one-day Variation
The Friedman rank test (6) was applied to the data in
order to investigate whether a systematic pattern ex-
isted in the consecutive parameter values during one
day. No such patterns were observed, except slight
trends for creatine kinase and aspartate aminotrans-
ferase (increase during the day) and serum bilirubin
concentration (decrease during the day).
In blood samples taken at different times of one day,
intra-individual variations were calculated. Two si-
tuations can occur: either CVT > CVS in which case
CVP is found positive or CVT ^ CVS in which case
CVP cannot be calculated and is set to zero.
The first Situation was observed for the great majori-
ty of the individuals for most parameters. For 20 of
the 28 parameters more than 85% of the participat-
ing individuals show a positive CVP. The results are
summarized in table 2.
The within-one-day intra-individual variations,
CVpso and CVp90 were almost all different from zero
for the serum constituents except for the CVp50 of
Tab. 2. Intra-individual Variation during one day (n = 62).
Analyte CVS CVp50 dKso CVP9o
Enzymes
Creatine kinase
Creatine
kinase-MB
Alanine amino-
transferase
Aspartate amino-
transferase
Lactate
dehydrogenase
a-Hydroxy-
butyrate
dehydrogenase
γ-Glutamyl-
transferase
Alkaline
phosphatase
a-Amylase
Electrolytes
Sodium
Potassium
Chloride
Calcium
Phosphate
Intermediary
metabolites
Bilirubin
Glucose
Cholesterol
Triglycerides
Total protein
Albumin
Urea
Creatinine
Uric Acid
Iron Status
Iron
Transferrin
Ferritin
Thyroid h rmones
Thyroxine (T4)
Triiodo-
thyronine (Ta)
96
95
86
95
89
79
96
94
100
73
100
86
79
96
100
100
87
100
92
81
95
94
94
89
84
25
30
51
1.7
4.3
0.9
0.9
2.1
2.8
1.3
0.9
1.2
0.6
1.0
1.0
0.8
1.4
1.6
1.5
1.8
2.8
1.3
1.8
1.8
1.6
1.0
3.8
1.9
10.0
6.0
5.7
8.3
13.5
5.3
4.7
5.0
4.3
5.7
2.7
4.4
0.6
4.6
1.1
1.8
10.4
13.4
13.3
2.8
14.3
2.3
2.4
4.8
3.4
5.4
9.4
3.0
0.0
0.0
0.4
'
 f24.0
40.1
15.2
13.5
15.3
14.5
16.5
8.0
12.9
2.4
13.3
4.2
5.6
29.7
38.2
37.9
9.4
41.2
7.5
8.5
14.5
10.6
15.5
28.7
10,0
28.2
17.0
16.1
18.5
25.1
10.3
9.4
9.7
10.0
12.8
5.1
9.4
1.4
7.8
2.4
3.6
19.6
24.9
25.8
6.4
33.9
4.7
5.0
9.7
6.8
9.8
22.3
5.7
11.4
6.0
10.4
52.5
72.0
29.2
26.7
28.1
29.4
36.4
14.6
26.8
4.3
22.2
7.4
10.4
55.6
70.6
73.1
18.8
96.2
13.8
15.0
27.9
19.8
27.9
64.0
17.0
42.9
24.0
33.5
nva percentage of individuals with CVT > CVS
median intra-individual coefficient of Variation
90 percentile of intra-individual coefficient of Variation
ferritin and thyroxine. As shown in table 2 the intra-
individual variations varied from 0.0-14.3%
(CVpso) and from 1.4-33.9% (CVp90). The critical
differences varied from 2.4-41.2% (<1κ5ο) and from
4.3-96.2% (dK9o).
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The Mann-Whitney test (7) was applied in order to
reveal those parameters showing differences in bio-
logical variations (CVP) and critical differences (dK)
between the 50 percentile values and the 90 percen-
tile values for the male/female groups, the smokers/
non smokers groups and the female groups using/not
using oral contraceptives.
The only significant statistical differences for serum
transferrin and triglycerides were found between the
male versus the female groups. Between male smok-
ers and non smokers significant statistical differences
were found for potassium, creatinine and ferritin.
Between female smokers and non smokers a signifi-
cant statistical difference was found for calcium. Be-
tween females with and without oral contraceptives
such differences were seen for aspartate aminotrans-
ferase, sodium and thyroxine (T4). Although the dif-
ferences are significant from a statistical point of
view, they seem to be of no importance in clinical
use.
Examination of scatter-diagrams and correlation
coefficients revealed no correlations between intra-
individual Variation and age, height, body weight and
levels of corresponding laboratory parameters. All
but the phosph te and glucose variations of the with-
in-one-day intra-individual variations are below or
equal to the month-to-month intra-individual varia-
tions (tab. 2, 5). It can thus be concluded that the
majority of the within-one-day intra-individual vari-
ations of clinical chemical parameters are smaller
than or similar to the month-to-month intra-individ-
ual variations.
In table 3 are summarized the critical differences
based on SL for both males and females, expressed in
SI units.
The use of dKso or dK90 is arbitrary. However, for
clinical decisions d^o is preferable for maximum
specifity, whereas greater sensitivity is obtained us-
ing
Tab. 3. Critical difference on one day based on SL.
Analyte Mean djcso doo Transverse
values reference values
Day-to-day Variation
Following the progress or the course of a disease or
.the response to treatment, the clinician may primari-
ly be interested in changes in the concentration of
serum constituents pccurring with an interval of two
to three days or a week. Therefore, we decided to
study the short term day-to-day Variation of 16
healthy individuals, this time span being interme-
diate between hours (within-one-day) and months.
In table 4 the day-to-day variations are given of sev-
en chemical parameters. These have beeil chosen
with regard to mineral metabolism (sodium, potassi-
um), enzyme pattern (alanine aminotransferase) and
S.I. units
Enzymes
Creatine
kinase
Creatine
kinase-MB
Alanine
amino-
transferase
Aspartate
amino-
transferase
Lactate
dehydro-
genase
a-Hydroxy-
butyrate
dehydro-
genase
γ-Glutamyl-
transferase
Alkaline
phosphatase
a-Amylase
Electrolytes
Sodium
Potassium
Chloride
Calcium
Phosphate
Intermediary
metabolites
Bilirubin
Glucose
Cholesterol
Triglycerides
Total protein
Albumin
Urea
Creatinine
Uric acid
Iron Status
Iron
Transferrin
Ferritin
Thyroid
hormones
Thyroxine
(T4)
Triiodothy-
ronine (Ta)
U/l
U/l
U/l
U/l
U/l
U/l
U/l
U/l
«
U/l
mmol/1
mmol/1
mmol/1
mmol/1
mmol/1
μπιοΐ/l
mmol/1
mmol/I
mmol/I
g/l
g/i
mmol/1
μΓηο1/1
mmol/1
μιηοΐ/l
g/i
ng/ml
nmol/1
nmol/I
103
10
13
19
281
124
16
72
117
144
4.3
107
2.5
1.1
8.3
4.4
4.6
1.17
73
48
4.5
86
0.26
19
3.1
66
109
2.4
28
4
2
3
46
21
3
7
19
5
0.6
6
0.2
0.3
3.2
1.7
0.5
0.50
6
5
0.7
10
0.05
6
0.4
23
24
0.5
56
7
4
5
81
38
6
11
33
7
1.0
9
0.3
0.6
5.9
3.2
0.9
1.13
10
8
1.3
18
0.08
12
0.6
31
30
0.8
<240
< 25
< 35
< 30
<450
90
4
50
70
133
3.5
95
2.2
0.9
3.4
3.5
4.0
-180
- 50
-125
-300
-145
- 5.1
-107
- 2.6
- 1.5
- 17.0
- 5.6
- 7.5
0.85- 2.00
65
35
3.0
45
- 80
- 50
- 7.0
-130
0.16- 0.43
10
2.0
12
60
1.3
- 30
- 3.7
-302
-150
- 3.0
Mean values are taken over all time points and all individuals
intermediary metabolism (glucose, urea, creatinine
and uric acid). AH but the sodium variations of the
day-to-day intra-individual variations are lower than
the month-to-month intra-individual variations
(vide infra).
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Tab. 4. Dav to day intra-individual for a group of sixteen healthy
individuals.
Intra-individual Variation
day to day month
t/%lO
month
(n =
0*7 A\Z/4)
Analyte Ivs2 Ivs3 Ivs4 Ivs5 Ivs7
(%) (%) (%) (%) (%) (%)
Alanine ami- CVP5n 13.5 9.2 10.6 13.3 18.6 30.0
notransferase CVP90 31.6 42.6 38.1 24.0 32.2 47.5
Sodium CVP50 0.6 0.0 1.3 0.8 0.0 0.5
CVP90 0.8 0.8 1.9 1.3 0.8 1.3
Potassium CVP5o 2.6 1.3 3.1 1.4 2.2 4.5
CVP90 6.6 3.0 6.4 5.2 6.7 7.3
Glucose CVp50 6.1 3.5 8.1 6.7 7.9 12.0
CVP90 17.2 11.7 16.8 11.3 16.8 20.8
Urea CVpso 10.6 8.0 7.9 8.7 5.8 11.2
CVp90 18.8 22.7 18.9 18.9 18.7 18.9
Creatinine CVP5o 2.8 2.7 2.5 2.7 2.1 5.7
CVp9o 7.4 5.0 5.4 5.8 6.9 13.6
Uric acid CVP50 4.4 5.9 4.2 7.7 6.7 8.0
CVP90 12.7 10.7 9.7 12.7 12.4 14.3
Month-to-month Variation
For the purpose of following the course of a chronic
disease or for monitoring healthy individuals in a
preventive medicine setting, we investigated month-
to-month variations over a period of six months. In-
tra-individual variations were calculated from the
analysis results of the blood samples taken every
month at the same time of the day during a period of
six months. Two situations can occur, either CVT >
CVs in which case CVP is found positive or CVj ^
CVS in which case CVP cannot be calculated and is
set to zero.
The Friedman rank test (6) was applied to clinical
chemical data from all individuals. No systematic low
or high values or trends were found. The results for
CVP are summarized in table 5.
Month-to-month intra-individual variations, CVpso
and CVp90 were all different from zero for all serum
constituents (tab. 5). The critical differences varied
from 2.2-89.1% (dK5o) and from 4.0-155.5%
Tab. 5. Intra-individual
ing six months
Analyte
Enzymes
Creatine kinase
Creatine
kinase-MB
Alanine amino-
transferase
Aspartate amino-
transferase
Lactate
dehydrogenase
a-Hydroxy-
butyrate
dehydrogenase
γ-Glutamyl-
transferase
Alkaline
phosphatase
cc^Amylase
Electrolytes
Sodium
Potassium
Chloride
Calcium
Phosphate
Intermediary
metabolites
Bilirubin
Glucose
Cholesterol
Triglycerides
Total protein
Albumin
Urea
Creatinine
Uric Acid
Iron Status
Iron
Transferrin
Ferritin
Thyroid hormones
Thyroxine (T4)
Triiodo-
thyronine (Ta)
Hvar(%)
100
100
100
1 ΛΠ1UU
100
99
100
100
100
67
100
86
97
100
100
100
100
100
96
94
100
99
100
100
97
82
72
82
Variation and the critical difference dur-
in = 274).
CVS
(%)
1.7
4.3
0.9
0 0.y
2.1
2.8
1.3
0.9
1.2
0.6
1.0
1.0
0.8
1.4
1.6
1.5
1.8
2.8
1.3
1.8
1.8
1.6
1.0
3.8
1.9
10.0
6.0
5.7
CVP50
(%)
22.8
31.2
30.0
10012.4
10.3
8.8
12.9
7.4
8.7
0.5
4.5
1,3
2.3
9.5
18.7
12.0
6.5
21.6
2.6
3.2
11,2
5.7 ~
8.0
19.8
5.8
12.8
4.8
5.7
dKso
(%)
• r
64.7
89.1
84.9
1Λ d34. 0
29.7
26.1
36.7
21.1
24.8
2.2
13.0
4.6
6.9
27.2
53.1
34.2
19.1
61.6
8.2
10.4
32.1
16.7
22.8
57.0
17.3
45.9
21.7
22.8
.
CVP90(%)
45.1
54.8
47.5
nc oZj.3
17.7
16.5
26.2
14.6
21.8
1.3
7.3
2.4
4.2
14.2
28.6
20.8
12.3
34.2
5.1
6.2
18.9
13.6
14.3
33.4
11.2
37.8
13.4
15.1
dK90
(%)
127.6
155.5
134.4
ΠΛ a/l. o
50.4
47.3
74.2
41.3
61,8
4.0
20.8
7.4
12.1
40.4
81.0
59.0
35.2
97.1
14.9
18.3
53.7
38.7
40.5
95.1
32.1
110.6
41.5
45.7
Using the Mann-Whitney test (7) we looked for sta-
tistically significant differences in intra-individual
variations between males and females. These have
been found for alkaline phosphatase, calcium, glu-
cose, cholesterol, total protein, albumin, urea, creat-
inine, uric acid, transferrin and ferritin. Between
found. In the groups of fenaale smokers and non
smokers aspartate aminotransferase, lactate dehy^
drogenase, α-hydroxybutyfate dehydrogenase, alka-
line phosphatase and albumin, however, showed
such differences. Between females taking or not tak-
ing °oral contraceptives, alkaline phosphatase, a-
amylase and thyroxine were sigqi^icantly different.
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The following differences are not only statistically,
but probably also clinically relevant: in the male/fe-
male group alkaline phosphatase, creatinine and fer-
ritin especially in the CVP90 and dK9o (tab. 6), in table
7 female smokers and non smokers lactate dehy-
drogenase, in the females taking/not taking oral con-
traceptives ct-amylase and thyroxine (tab. 8).
Tab. 6. Significant differences in the intra-individual variations
during six months between males and females (p < 0.05).
Analyte
Alkaline
phosphatase
Calcium
Glucose
Cholesterol
Total protein
Albumin
Urea
Creatinine
Uric acid
Transferrin
Ferritin
Sex
0*
9
β
9
δ
9
δ
9
6
9
i
ο+
S
9
β
9
<j
9
β
9
β
9
n
148
126
148
126
148
126
148
126
148
126
148
126
148
126
148
126
148
126
148
126
148
126
CVS
0.9
0 8\JrnO
1.5
1 0.8
1.3
1.8
1 8i .0
1 6JL m\J
1.0
1 f\.y
10.0
CVpso dicso CVp9o dic90
6.9
8.2
2.2
2.6
13.2
10.4
6.0
7.2
2.3
3.2
2.7
4.2
9.7
12.2
6.2
5.3
7.4
9.0
5.6
6.4
9.0
17.1
19.7
23.3
6.6
7.7
37.6
29.7
17.7
21.0
7.5
9.8
9.2
12.9
27.9
34.9
18.1
15.7
21.1
25.6
16.7
18.9
38.1
56.0
12.2
17.8
4.0
4.3
22.4
20.1
10.8
14.1
4.3
5.7
5.1
7.0
17.8
21.4
17.4
11.7
13.6
15.5
10.7
12.3
31.4
43.9
34.6
50.4
11.5
12.4
63.5
57.0
31.0
40.2
12.7
16.5
15.3
20.4
50.6
60.7
49.4
33.4
38.6
43.9
30.7
35.2
93.2
127.3
Tab. 8. Significant differences in the intra-individual variations
during six months between females using/not using oral
contraceptives (p < 0.05).
Oral n CVS CVP5o dKso CVP9o dK90
con-
tra-
cep-
tives f%^ f%^ (°/ ^ (°/ ^ (°/ \
Alkaline + 61
 0 9 9'2 26J 19'4 54·9phosphatase - 59 ' 7.6 21.6 16.8 47.6
α-Amylase + 61 i 9 9·6 27·4 28·5 80·7
59 ' 8.6 24.6 16.1 45.7
Thyroxine + 61 5 0 7'9 28<1 16·6 49·9
(T4) - 59 ' 4.3 20.9 10.2 33.5
Examining scatter diagrams and correlation coeffi-
cients we found no correlations between intra-indi-
vidual Variation and age, height, body weight and
levels of corresponding laboratory parameters. In ta-
ble 9 are summarized the critical differences (dicso
and dK9o) based on SL for both males and females
expressed in absolute values (SI units).
Discussion
From a study of the literature on the (intra-individu-
al) variability of laboratory data, it soon appeared
that valid comparison with our data was very diffi-
cult. Many published investigations were concerned
n = number of persons
Tab. 7. Significant differences in the intra-individual variations
during six months between female smokers/non-smokers
(p < 0.05).
Analyte
Aspartate
amino-
transferase
Lactate de-
hydrogenase
a-Hydroxy-
butyrate de-
hydrogenase
Alkaline
phosphatase
Albumin
Smokers
Non-smokers
Smokers
Non-smokers
Smokers
Non-smokers
Smokers
Non-smokers
Smokers
Non-smokers
n
54
72
54
72
54
72
54
72
54
72
CVS
0.9
2.1
2.8
0.9
1.8
CVpso 4κ50 CVp90 dx90
13.6
10.3
11.9
9.1
9.9
7.9
9.3
7.5
3.8
4.4
38.6
29.2
34.2
26.4
29.1
23.7
26.4
21.4
11.9
13.4
26.7
21.5
20.0
13.3
17.6
14,2
19.0
16.5
7.0
7.0
75.6
60.9
56.9
38.1
50.4
40.9
53.8
46.7
20.4
20.4
statistical evaluation f intra-individual Variation.
Moreover, only a few of them paid sufficient atten-
tion to the pre-analytical conditions (such s blood
taking equipment, "other" factors) and to the ana-
lytical procedure.
Investigators such s Steigterhem et al. (10) have stu-
died the analytical intra-individual and inter-individ-
ual components of variance in a group of only 10
volunteers for 34 assays encompassing 22 different
constituents. Replicate blood specimens were ob-
tained four times weekly over a 4 week period. Nine
constituents were measured with more than one in-
strument. In those studied analytical variances of
more than 30% of total variance have been report-
ed. The use of different analysers can be considered
to be the main cause of the different (sometimes
large) analytical variances s^. This is in contrast with
our study where all analyses were performed in such
a way that s^ is kept s low s possible.
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Tab. 9. The critical differences observed during six months for
males and fcmales based on SL-
Analyte Mean dKso dK90 Transverse
values reference values
S.I. units
Enzymes
Creatine
kinase
Creatine
kinase-MB
Alanine
amino-
transferase
Aspartate
amino-
transferase
Lactate
dehydro-
genase
a-Hydroxy-
butyrate
dehydro-
genase
γ-Glutamyl-
transferase
Alkaline
phosphatase
a-Amylase
Electrolytes
Sodium
Potassium
Chloride
CaJcium
Phosphate
U/l
U/l
U/l
U/l
U/l
U/l
U/l
U/l
U/l
mmol/1
mmol/1
mmol/1
mmol/1
mmol/1
98
11
15
20
286
114
22
71
122
142
4.4
103
2.4
1.1
63
10
13
7
85
30
8
15
30
3
0.6
5
0.2
0.3
125
17
20
14
144
54
16
29
75
6
0.9
8
0.3
0.4
<240
< 25
< 35
< 30
<450
90
4
50
70
133
3.5
95
2.2
0.9
-180
- 50
-125
-300
-145
- 5.1
-107
- 2.6
- 1.5
Intermediary
metabolites
Bilirubin μηαοΐ/ΐ
Glucose mmol/1
Cholesterol mmol/1
Triglycerides mmol/1
Total protein g/l
Albumin g/l
Urea mmol/1
Creatinine μπιοΐ/ΐ 85
Uric acid mmol/1
Iron Status
Iron μπιοΐ/ΐ 19 11
Transferrin g/l 3.2 0.6
Ferritin ng/ml 74 34
Thyroid
hormones
Thyroxine nmol/1 109 24
(T4)
Triiodothy- nmol/1 2.3 0.5
ronine (T3)
8.1
4.4
5.4
1.60
'2
4.9
\
0.27
4.
1.
1.
0.
6
4
1.
14
3
5
0
99
6
0.06
6.6
2.6
1.
1.
11
8
2,
33
,9
.55
,6
0.11
3.4 -
3
4
0
65
35
3
45
.5 -
.0 -
.85-
—
—
.0 -
17.0
5.6
7.5
2.00
80
50
7.0
-130
0.16- 0.43
18
1.0
82
45
1.1
10 - 30
2.0 - 3.7
12 -302
60 -150
1.3 - 3.0
Mean values are taken over all months and all individuals
Harris et al. (11) applied Standard statistical analysis
of variance on data from weekly determinations of
15 blood constituents in each of 68 normal subjects,
over a 3 months period. The p rpose was to isolate
and estimate the biological components of the ob-
served Variation. The most critical problem, i.e. se-
parating variations from long-term analytical devia-
tions in each mdividual's data record, were resolved
with the aid of concurrent analysis of an ass yed con-
trol serum. They stated that comparison of isolated
personal variations with inter-individual variations
indicate that many common blood tests could con-
tribute to an individually distinctive blood "profile"
if substantial improvements could be made in analyt-
ical precision. This is in accordance with our opinion.
However, the number of parameters and partici-
pants in their study was smaller than in our study and
their analytieal variances seemed to be too large.
Young et al. (12) sampled blood, under controlled
conditions, from 9 healthy subjects weekly for 10
weeks. Eighteen serum constituents were measured
in duplicate in each sample in a single analytical run.
In this way the analytical Variation was minimised.
Considerable variations in mean values and Standard
deviations of results were observed among the sub-
jects. Compared with a previ s study (11) from
their laboratory, significantly different estimates of
personal Variation were noted for a number of con-
stituents. The group studied showed s great a diver-
sity in the mean concentrations of most constituents
s was seen earlier in a lajger, more heterogeneous
group of normal individuals. The authors concluded
that certain blood parameters depend more on per-
sonal characteristics than on broad demographic f c-
tors. It can be doubted whether their conclusions
have general validity becausQ only 9 persons partici-
pated in their study.
Winkel et al. (13) evaluated the variations in some
serum constituents in a group of 11 healthy young
men for two selected time intervals; short term d y-
to-day changes over a six day period and hour-to-
hour changes over two six hour periods in different
weeks. Analytical variations appeared to be of con-
siderable influence on total variations. It must be re-
marked that the group size is too small to obtain gen-
erally valid data.
Pickup et al. (14) stressed the importance of high-
capacity multi-channel analysers for the estimation
of long-term variability in serum constituents. By
frozen storage of specimens from 37 volunteers (20
males/17 females) with subsequent analysis in a sin-
gle machine run, long-term analytical Variation may
be eliminated, thus sharpening the estimates of in-
tra-individual Variation. The usual population-based
reference ranges were found to be either insensitive
or irrelevant to the study of conceiitration changes
over time in most healthy subjects.
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Lommel & Weyer (9) studied a large group of highly
selected origin, i.e. male soldiers between 18 and 23
years of age. This of course eliminates several influ-
ences such äs age, sex, etc. but diminishes the applic-
ability of their results to general practice.
Williams et al. (15) studied a group of 1105 individu-
als. Analyses were performed in weekly blood sam-
ples over a 12 weeks period. The assumption was
tested that a reference group of individuals, sub-di-
vided by age and sex, would give a narrower ränge of
Variation than does a larger mixed population. Their
results implied the need for individual rather than
population-based reference ranges, even if the latter
were from persons of similar age and the same sex.
Although in their study factors influencing the Sp
were not been considered, their conclusions are in
accordance with our results.
Conclusions
In general, the conclusions of the investigations re-
ported by others have sometimes limited value and
are not in accordance with our data (tab. 10). Due to
the relatively small number of participants in inost of
the described studies no meaning could be attributed
to differences within groups such äs male/female,
smokers/non smokers, age intervals, body weight,
height and females taking/not taking oral contracep-
tives. In our work, greater importance can be att-
ached to these differences espeaally in those pa-
rameters where the analytical imprecision is very
small (19). It is not ünexpected that in determina-
tions with greater analytical imprecision the pre-ana-
lytical influeiices are less pronounced.
In agreement with other investigators (16, 17) we
state that the current use of "reference values"
should now be reconsidered. The main reason is that
reference ranges for many parameters are often
much larger than the ränge of physiological intra-in-
dividual variations. Intuitively physicians do esti-
mate intra-individual changes in laboratory values
far higher than the general "reference values".
It can be concluded that the use of .general transverse
reference ranges is only suitable when pathology is
accompanied by gross deviations.
Tab. 10. Published intra-individual variations (CVP).
Literature (10) (11) (12) (13) (14) (15) Our
references study
n
Enzymes
Creatine
kinase
Alanine ami-
notransferase
Aspartate ami-
notransferase
Lactate de-
hydrogenase
-Glutamyl-
transferase
Alkaline
phosphatase
a-Amylase
Electrolytes
Sodium
Potassium
Chloride
Calcium
Phosphate
Intermediary
metabolites
Bilirubin
Glucose
Cholesterol
Triglycerides
Total protein
Urea
Creatinine
Uric acid
Iron Status
Iron
10
82.76
57.89
14.79
6.19
-
6.33
—
0.93
4.43
1.52
- 1.93
7.40
25.59
—4.39
33.33
2.51
14.29
3.83
8.98
-
68
—
-
—
9.0
-
-
-
—5.0
1.4
1.7
7.5
—5.6
6.4
2.8
11.9
—10.1
-
9
—
—
15.1
7.3
-
5.8
—
1.4
4.6
2.1
1.6
9.6
—6.5
4.2
2.3
13.6
4.4
8.5
-
11
—
26.4
24.2
-
-
4.8
—
0.7
4.3
2.1
1.7
5.8
22.0
—
5.3
2.9
12.3
4.3
7.3
26.6
37
—
-
—
—
-
6.4
—
0.5
6.2
-
1.6
6.8
26.0
-
-
3.0
11.1
—
—
-
1105
60.3
—
19.3
8.0
34.7
8.5
—
—
—
—2.1
8.2
—6.5
7.9
27.3
3.3
16.4
3.1
8.8
-
274
22.8
30.0
12.2
10.3
12.9
7.4
8.7
0.5
4.5
1.3
2.3
9.5
18.7
12.0
6.5
21.6
2.6
11.2
5.7
8.0
19.8
The use of intra-individual variations and calculated
critical differences improve the value of laboratory
data in diagnosis and treatment, because abnormal
changes in paraineter values in an individual within
the transverse reference interval can be detected.
We agree with others (9, 16) in regarding the neces-
sity of considering the individual äs his own refer-
ence and the use of critical difference values in longi-
tudinal studies. It can be remarked that in screening
for early detection of disease new decision limits
must be determined which are different from the tra-
ditional transverse reference ranges (18).
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